Clinical Trials Directory

Trials / Completed

CompletedNCT00171236

Efficacy and Safety of Fluvastatin in Children With Heterozygous Familial Hypercholesterolemia

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
84 (actual)
Sponsor
Novartis · Industry
Sex
All
Age
10 Years – 16 Years
Healthy volunteers
Not accepted

Summary

The purpose of the study is to assess the safety and efficacy of fluvastatin in children diagnosed with heterozygous familial hypercholesterolemia

Conditions

Interventions

TypeNameDescription
DRUGFluvastatin

Timeline

Start date
2001-10-01
Primary completion
2005-03-01
Completion
2005-03-01
First posted
2005-09-15
Last updated
2011-11-08

Locations

1 site across 1 country: Switzerland

Source: ClinicalTrials.gov record NCT00171236. Inclusion in this directory is not an endorsement.

Efficacy and Safety of Fluvastatin in Children With Heterozygous Familial Hypercholesterolemia (NCT00171236) · Clinical Trials Directory